WHC is still in active development. Read this to understand our approach.
depiction of JDNLPKCAXICMBW-UHFFFAOYSA-N.svg
psychonaut

JWH-018

Verificar en psychonaut

isomerdesign

JWH-018

Verificar en isomerdesign

pubchem

1-Pentyl-3-(1-naphth...

Verificar en pubchem

wiki

JWH-018

Verificar en wiki

Data

InChI: InChI=1S/C24H23NO/c1-2-3-8-16-25-17-22(20-13-6-7-15-23(20)25)24(26)21-14-9-11-18-10-4-5-12-19(18)21/h4-7,9-15,17H,2-3,8,16H2,1H3

Sinónimos: UNII-G391998J57,1-Pentyl-3-(1-naphthoyl) indole,G391998J57,Methanone, 1-naphthalenyl(1-pentyl-1H-indol-3-yl)-,Q419020,JWH-018 ((Naphthalen-1-yl)(1-pentylindol-3-yl)methanone) 0.1 mg/ml in Acetonitrile,BCP27424,1-Naphthalenyl-(1-pentyl-1H-indol-3-yl)methanone,(1-Pentyl-1H-indol-3-yl)-1-naphthalenylmethanone,10.14272/JDNLPKCAXICMBW-UHFFFAOYSA-N.1,209414-07-3,1-pentyl-3-1-naphthoyl-indole,CCG-208715,CHEMBL561013,A14168,DTXSID10175117,ZINC13476531,JWH-018 ((Naphthalen-1-yl)(1-pentylindol-3-yl)methanone),naphthalen-1-yl(1-pentyl-1H-indol-3-yl)methanone,DB-003103,DS-3151,GTPL9706,ACT06673,Q-200132,414P073,Naphthalen-1-yl-(1-pentylindol-3-yl)methanone,(Naphtalin-1-yl)(1-pentyl-1H-indol-3-yl)methanon,JWH-018,SCHEMBL1707018,JWH 018,BDBM50353747,CHEBI:185787,NCGC00386566-01,J770.893I,JWH-018 ((Naphthalen-1-yl)(1-pentylindol-3-yl)methanone) 1.0 mg/ml in Acetonitrile,JWH018,Naphthalen-1-yl(1-pentylindol-3-yl)methanone,A4549,DEA No. 7118,AM 678,doi:10.14272/JDNLPKCAXICMBW-UHFFFAOYSA-N.1,HSDB 7998,Naphthaten-1-yl-(1-pentylindol-3-yl)methanone,NA-PIMO,AKOS005145577,1-Pentyl-3-(1-naphthoyl)indole,1-pentyl-3-(1-naphthoyl)-indole,AM-678,JWH-018,1-Ii>>u-3-(1-YA(1/4)xo pound>>u)ssAssa,JWH-018 solution, 100 mug/mL in methanol, ampule of 1 mL, (Spice Cannabinoid), certified reference material

Market name: jwh-018

Estimated data

Solubilidad: -6.672 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: No (prediction using frontiersin.org)

Addictivity Prediction: 99.4% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.